{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:26:06Z","timestamp":1786998366470,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"vor","delay-in-days":56,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ymgme.2021.09.004","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T06:21:53Z","timestamp":1633155713000},"page":"250-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Correlations of blood and brain biochemistry in phenylketonuria: Results from the Pah-enu2 PKU mouse"],"prefix":"10.1016","volume":"134","author":[{"given":"Allysa M.","family":"Dijkstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninke","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danique","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan C.J.","family":"Huijbregts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"van der Goot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris B.","family":"Hovens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy A.","family":"van der Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido P.","family":"Kema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Rebecca","family":"Heiner-Fokkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francjan J.","family":"van Spronsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0005","first-page":"1","article-title":"Phenylketonuria","volume":"7","author":"van Spronsen","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2021.02.008","article-title":"Effect of BH4 on blood phenylalanine and tyrosine variations in patients with phenylketonuria","volume":"133","author":"Wegberg","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.09.004_bb0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ebiom.2018.10.038","article-title":"Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials","volume":"37","author":"Gupta","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymgme.2021.09.004_bb0020","first-page":"1","article-title":"Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria","volume":"00","author":"Qi","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete European guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"Van Wegberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2021.09.004_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","article-title":"Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis","volume":"92","author":"Waisbren","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.004_bb0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1037\/neu0000336","article-title":"The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: effects across tasks and developmental stages","volume":"31","author":"Romani","year":"2017","journal-title":"Neuropsychology"},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0040","first-page":"60","article-title":"Quality of dietary control in phenylketonuric patients and its relationship with general intelligence","volume":"25","author":"Vilaseca","year":"2010","journal-title":"Nutr. Hospital."},{"issue":"4","key":"10.1016\/j.ymgme.2021.09.004_bb0045","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ymgme.2013.09.001","article-title":"Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes","volume":"110","author":"Cleary","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.004_bb0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10545-016-9918-0","article-title":"Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study","volume":"39","author":"Jahja","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.004_bb0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2011.05.017","article-title":"PKU: high plasma phenylalanine concentrations are associated with increased prevalence of mood swings","volume":"104","author":"Anjema","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.004_bb0060","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00004647-200103000-00011","article-title":"Variability of blood\u2014brain ratios of phenylalanine in typical patients with phenylketonuria","volume":"21","author":"Rupp","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.004_bb0065","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jimd.12049","article-title":"Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria","volume":"42","author":"Pilotto","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.09.004_bb0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/mrm.21983","article-title":"Reproducibility of cerebral phenylalanine levels in patients with phenylketonuria determined by 1H-MR spectroscopy","volume":"62","author":"Kreis","year":"2009","journal-title":"Magn. Reson. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-133","article-title":"Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis","volume":"8","author":"de Groot","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.004_bb0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1212\/WNL.0000000000011088","article-title":"Phenylalanine effects on brain function in adult phenylketonuria","volume":"96","author":"Pilotto","year":"2021","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.ymgme.2021.09.004_bb0085","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1017\/S0033291717001398","article-title":"Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria","volume":"47","author":"Boot","year":"2017","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0090","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1007\/PL00014257","article-title":"Neurotransmitter positron emission tomographic-studies in adults with phenylketonuria, a pilot study","volume":"155","author":"Paans","year":"1996","journal-title":"Eur. J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2021.09.004_bb0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1005621727560","article-title":"Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria","volume":"23","author":"Leuzzi","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.09.004_bb0100","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.ymgme.2009.10.181","article-title":"Animal models of brain dysfunction in phenylketonuria","volume":"99","author":"Martynyuk","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2021.09.004_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143833","article-title":"Large neutral amino acid supplementation exerts its effect through three synergistic mechanisms: proof of principle in phenylketonuria mice","volume":"10","author":"van Vliet","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ymgme.2021.09.004_bb0110","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3945\/ajcn.116.135996","article-title":"Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model","volume":"104","author":"Van Vliet","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2021.09.004_bb0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jnutbio.2017.09.020","article-title":"Large neutral amino acid supplementation as an alternative to the phenylalanine-restricted diet in adults with phenylketonuria: evidence from adult Pah-enu2 mice","volume":"53","author":"van Vliet","year":"2018","journal-title":"J. Nutr. Biochem."},{"issue":"9","key":"10.1016\/j.ymgme.2021.09.004_bb0120","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3390\/nu11092252","article-title":"The benefit of large neutral amino acid supplementation to a liberalized phenylalanine-restricted diet in adult phenylketonuria patients: evidence from adult Pah-enu2 mice","volume":"11","author":"Van Vliet","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ymgme.2021.09.004_bb0125","series-title":"Committee on Care, Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals","author":"Institute of Laboratory Animal Resources (US)","year":"1978"},{"key":"10.1016\/j.ymgme.2021.09.004_bb0130","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/jn\/123.11.1939","article-title":"Purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformation of the AIN-76A rodent diet","volume":"123","author":"Reeves","year":"1993","journal-title":"J. Nutr."},{"issue":"4","key":"10.1016\/j.ymgme.2021.09.004_bb0135","doi-asserted-by":"crossref","first-page":"1016S","DOI":"10.1093\/jn\/130.4.1016S","article-title":"Transport of glutamate and other amino acids at the blood-brain barrier","volume":"130","author":"Smith","year":"2000","journal-title":"J. Nutr."},{"issue":"4","key":"10.1016\/j.ymgme.2021.09.004_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ymgme.2009.12.007","article-title":"Classical maple syrup urine disease and brain development: principles of management and formula design","volume":"99","author":"Strauss","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2021.09.004_bb0145","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1152\/physrev.1983.63.4.1481","article-title":"Brain metabolism: a perspective from the blood-brain barrier","volume":"63","author":"Pardridge","year":"1983","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymgme.2021.09.004_bb0150","series-title":"Straightforward Statistics for the Behavioral Sciences","author":"Evans","year":"1996"},{"key":"10.1016\/j.ymgme.2021.09.004_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fnbeh.2016.00233","article-title":"The behavioral consequence of phenylketonuria in mice depends on the genetic background","volume":"10","author":"Bruinenberg","year":"2016","journal-title":"Front. Behav. Neurosci."},{"issue":"12","key":"10.1016\/j.ymgme.2021.09.004_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084697","article-title":"Behavioral and neurochemical characterization of new mouse model of hyperphenylalaninemia","volume":"8","author":"Pascucci","year":"2013","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.ymgme.2021.09.004_bb0165","doi-asserted-by":"crossref","first-page":"19392","DOI":"10.1016\/S0021-9258(19)77645-5","article-title":"Neutral amino acid transport at the human blood-brain barrier","volume":"263","author":"Hargreaves","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1005327801588","article-title":"In vivo NMR spectroscopy in patients with phenylketonuria: clinical significance of interindividual differences in brain phenylalanine concentrations","volume":"21","author":"Weglage","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1346","key":"10.1016\/j.ymgme.2021.09.004_bb0175","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1098\/rstb.1996.0134","article-title":"Evidence for the importance of dopamine for prefrontal cortex functions early in life","volume":"351","author":"Diamond","year":"1996","journal-title":"Philos. Trans. R. Soc. Lond. B"},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2891-12-60","article-title":"Diurnal variation of phenylalanine and tyrosine concentrations in adult patients with phenylketonuria: subcutaneous microdialysis is no adequate tool for the determination of amino acid concentrations","volume":"12","author":"Grunert","year":"2013","journal-title":"Nutr. J."},{"issue":"13","key":"10.1016\/j.ymgme.2021.09.004_bb0185","first-page":"485","article-title":"Daily blood sugar and hemoglobin A1 or A1c profile for the surveillance of diabetes therapy","volume":"110","author":"Berger","year":"1980","journal-title":"Schweizerische Medizinische Wochenschrift"},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.004_bb0190","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10545-017-0109-4","article-title":"Structural elucidation of novel biomarkers of known metabolic disorders based on multistage fragmentation mass spectra","volume":"41","author":"V\u00e1clav\u00edk","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.004_bb0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmedgenet-2019-106278","article-title":"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalised therapy: the challenge for the future guidelines","volume":"57","author":"Leuzzi","year":"2020","journal-title":"J. Med. Genet."},{"issue":"11","key":"10.1016\/j.ymgme.2021.09.004_bb0200","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.3390\/nu11112572","article-title":"Untreated PKU patients without intellectual disability: what do they teach us?","volume":"11","author":"Van Vliet","year":"2019","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.ymgme.2021.09.004_bb0205","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1172\/JCI5017","article-title":"Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria","volume":"103","author":"Pietz","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2021.09.004_bb0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01799701","article-title":"Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function","volume":"9","author":"G\u00fcttler","year":"1986","journal-title":"J. Inherit. Metab. Dis."},{"issue":"18","key":"10.1016\/j.ymgme.2021.09.004_bb0215","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1097\/00001756-200212200-00036","article-title":"Deficits in brain serotonin synthesis in a genetic mouse model of phenylketonuria","volume":"13","author":"Pascucci","year":"2002","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.ymgme.2021.09.004_bb0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF01799677","article-title":"The effect of plasma valine, isoleucine and leucine on the control of the flux through tyrosine-and tryptophan-hydroxylase in the brain","volume":"13","author":"Hommes","year":"1990","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10545-008-0946-2","article-title":"Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?","volume":"32","author":"Van Spronsen","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-133","article-title":"Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis","volume":"8","author":"de Groot","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0235","first-page":"23","article-title":"Dietary threonine reduces plasma phenylalanine levels in patients with hyperphenylalaninemia","volume":"36","author":"Sanjurjo","year":"2003","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2021.09.004_bb0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1651-2227.1994.tb13452.x","article-title":"Indications of changed amino acid homeostasis in untreated and treated PKU","volume":"83","author":"Hjelm","year":"1994","journal-title":"Acta Paediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2021.09.004_bb0245","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0197-0186(83)90106-7","article-title":"Mechanism of l-histidine-induced stimulation of amino acid transport in slices of rat cerebral cortex","volume":"5","author":"Korpi","year":"1983","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.ymgme.2021.09.004_bb0250","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/87565640903325725","article-title":"A preliminary investigation of the role of the phenylalynine: tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of \u201csafe\u201d levels","volume":"35","author":"Sharman","year":"2009","journal-title":"Dev. Neuropsychol."},{"issue":"6","key":"10.1016\/j.ymgme.2021.09.004_bb0255","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/ajcn\/64.6.916","article-title":"Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria","volume":"64","author":"van Spronsen","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.ymgme.2021.09.004_bb0260","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10545-017-0131-6","article-title":"Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients","volume":"41","author":"Coene","year":"2018","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:51:17Z","timestamp":1761090677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221007800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1096719221007800"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.09.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlations of blood and brain biochemistry in phenylketonuria: Results from the Pah-enu2 PKU mouse","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}